{"id":347172,"date":"2026-11-14T17:58:07","date_gmt":"2026-11-14T12:28:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/nath-bio-genes-q2-results-fy27-pat-0-42-crore\/"},"modified":"2026-11-14T17:58:07","modified_gmt":"2026-11-14T12:28:07","slug":"nath-bio-genes-q2-results-fy27-pat-0-42-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nath-bio-genes-q2-results-fy27-pat-0-42-crore\/","title":{"rendered":"Nath Bio-Genes Q2 Results FY27: Revenue Down 7.09% YoY to Rs 40.74 Cr, PAT Rs 0.42 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Nath Bio-Genes Q2 Results FY27 were declared on 14 November 2026, with consolidated revenue of Rs 40.74 Cr, down 7.09% YoY, and net profit of Rs 0.42 Cr, down 84.73% YoY. These quarterly results cover July to September 2026. The YoY growth figures sit beside Operating Profit of Rs 4.64 Cr against Rs 6.10 Cr a year earlier, a move of -23.93% YoY.<\/p>\n<\/div>\n

Nath Bio-Genes (India) Ltd<\/a> (NATHBIOGEN) Q2 Results FY27 announced on 14 November 2026, covering the company’s financial performance for the July to September quarter. The results date brings consolidated results with revenue of Rs 40.74 Cr and PAT of Rs 0.42 Cr, against Rs 2.75 Cr a year earlier. This Nath Bio-Genes Q2 Results FY27 report sets out each figure in full.<\/p>\n

This Nath Bio-Genes Q2 Results results analysis covers the financial highlights, the business drivers, the outlook and the risks that sit beside the numbers. Univest Screener users can follow the same disclosures, and the Financial Highlights below place the reported figures side by side.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n